Telix Pharmaceuticals | TLX - Market Capitalization

Stock Price
12.41
Daily Change
0.02 0.16%
Monthly
18.98%
Yearly
-55.36%
Q1 Forecast
11.05

Telix Pharmaceuticals reported AUD4.01B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cochlear AUD 11.28B 5.76B Mar/2026
CSL USD 71.32B 15.44B Mar/2026
Integral Diagnostics AUD 1.08B 457.31M Dec/2024
Mayne Pharma AUD 197.37M 55.3M Mar/2026
Medical Developments International AUD 33.66M 28.87M Mar/2026
Mesoblast USD 1.39B 2.16B Jun/2025
Neuren Pharmaceuticals AUD 1.51B 851.62M Mar/2026
Pacific Edge NZD 194.21M 87.84M Dec/2025
Paradigm Biopharmaceuticals AUD 89.55M 56.14M Mar/2026
Polynovo AUD 645.37M 204.37M Mar/2026
PYC Therapeutics AUD 7.21B 6.24B Mar/2026
Ramsay Health Care AUD 9.35B 1.42B Mar/2026
ResMed USD 52.52B 14.69B Dec/2025
Sonic Healthcare AUD 9.97B 1.21B Mar/2026